semaglutide and tirzepatide together vs Switching from Semaglutide to Tirzepatide:

For years, airtight patent protection in every major market kept generic competition completely off the table

During the first nine months of the year, Eli Lillys tirzepatide drugs Zepbound and Mounjaro raked in more than $11 billion in revenue, while Novo Nordisk reported combined revenue of more than $27 billion for its diabetes and obesity care business, including Wegovy and Ozempic, during the same time period

Provincial governments classify obesity medications as lifestyle drugs rather than essential medical treatments

For decades, injectable diabetes medications meant insulin

The statements below are direct attributions to peer-reviewed preclinical studies